Berman Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $23K | Buy |
500
+65
| +15% | +$2.99K | ﹤0.01% | 932 |
|
|
2021
Q2 | $21K | Buy |
435
+91
| +26% | +$4.39K | ﹤0.01% | 886 |
|
|
2021
Q1 | $15K | Sell |
344
-1,630
| -83% | -$71.1K | ﹤0.01% | 893 |
|
|
2020
Q4 | $90K | Buy |
1,974
+9
| +0.5% | +$410 | 0.02% | 268 |
|
|
2020
Q3 | $92K | Buy |
1,965
+1,335
| +212% | +$62.5K | 0.03% | 240 |
|
|
2020
Q2 | $31K | Sell |
630
-496
| -44% | -$24.4K | 0.01% | 427 |
|
|
2020
Q1 | $52K | Buy |
1,126
+614
| +120% | +$28.4K | 0.02% | 288 |
|
|
2019
Q4 | $30K | Buy |
512
+2
| +0.4% | +$117 | 0.01% | 427 |
|
|
2019
Q3 | $27K | Sell |
510
-15
| -3% | -$794 | 0.01% | 426 |
|
|
2019
Q2 | $26K | Buy |
525
+193
| +58% | +$9.56K | 0.01% | 440 |
|
|
2019
Q1 | $17K | Sell |
332
-363
| -52% | -$18.6K | 0.01% | 494 |
|
|
2018
Q4 | $32K | Buy |
+695
| New | +$32K | 0.01% | 305 |
|